Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "A new SARS-CoV-2 variant with high lethality poorly detected by RT-PCR on nasopharyngeal samples: an observational study" [Clin Microbiol Infect 28 (2) (2022) 298.e9-e15].
Fillâtre P, Dufour MJ, Behillil S, Vatan R, Reusse P, Gabellec A, Velmans N, Montagne C, Du Coudret SG, Droumaguet E, Merour V, Enouf V, Buzelé R, Valence M, Guillotel E, Gagnière B, Baidaliuk A, Zhukova A, Tourdjman M, Thibault V, Grolhier C, Pronier C, Lescure FX, Simon-Loriere E, Costagliola D, Van Der Werf S, Tattevin P, Massart N. Fillâtre P, et al. Among authors: enouf v. Clin Microbiol Infect. 2026 Apr 13:S1198-743X(26)00197-7. doi: 10.1016/j.cmi.2026.04.013. Online ahead of print. Clin Microbiol Infect. 2026. PMID: 41985673 No abstract available.
Influenza Vaccine Effectiveness in European Primary Care Pediatric Practices: 2022-2024.
Lucaccioni H, Maurel M, Pérez-Gimeno G, Buda S, Sève N, Domegan L, de Lange M, Rodrigues AP, Martínez-Baz I, Hagey TS, Mlinarić I, Túri G, Lazar M, García Becerril M, Dürrwald R, Enouf V, O'Leary M, Meijer A, Guiomar R, Trobajo-Sanmartín C, Latorre-Margalef N, Ilić M, Vázquez Rincón IM, Erdwiens A, Falchi A, McKenna A, Hooiveld M, Gómez V, Castilla J, Višekruna Vučina V, Pozo F, Bacci S, Kaczmarek M, Kissling E; European primary care VE group. Lucaccioni H, et al. Among authors: enouf v. Pediatrics. 2026 May 1;157(5):e2025072907. doi: 10.1542/peds.2025-072907. Pediatrics. 2026. PMID: 41936398
Vaccine effectiveness against medically attended, laboratory-confirmed influenza in the I-MOVE primary care network in Europe, VEBIS project, 2024/25.
Lucaccioni H, Pozo F, Pérez-Gimeno G, Dürrwald R, Uras M, Domegan L, Oroszi B, Meijer A, Trobajo-Sanmartín C, Ujvari D, Rodrigues AP, Mlinarić I, Lazar M, Rivas Wagner E, Erdwiens A, Enouf V, McKenna A, Túri G, de Lange M, Martínez-Baz I, Latorre-Margalef N, Guiomar R, Kurečić Filipovic S, Dinu S, Mokoroa O, Tolksdorf K, Masse S, Bennett C, Kristóf K, Hooiveld M, Castilla J, Santos J, Višekruna Vučina V, Popescu R, Bacci S, Kaczmarek M, Kissling E. Lucaccioni H, et al. Among authors: enouf v. Expert Rev Vaccines. 2026 Dec;25(1):2645378. doi: 10.1080/14760584.2026.2645378. Epub 2026 Mar 17. Expert Rev Vaccines. 2026. PMID: 41816931 Free article.
Influenza vaccine effectiveness from nine studies during drifted A(H3N2) subclade K predominance, Europe, September 2025 to January 2026.
Lucaccioni H, Marques DF, Kirsebom F, Emborg HD, Hamilton M, Whitaker H, Bolt Botnen A, Bucholc M, Pozo F, Andrews N, Trebbien R, Hameed SS, Lauenborg Møller K, O'Doherty MG, Lopez-Bernal J, Morrison K, Cottrell S, Wilton S, Rose AM, Kissling E; European IVE group. Lucaccioni H, et al. Euro Surveill. 2026 Feb;31(7):2600109. doi: 10.2807/1560-7917.ES.2026.31.7.2600109. Euro Surveill. 2026. PMID: 41716088 Free PMC article.
Interim vaccine effectiveness against influenza virus among outpatients, France, October 2025 to January 2026.
De Clercq A, Blanquart F, Vieillefond V, Visseaux B, Jacques A, Haim-Boukobza S, Wehrle V, Deleglise G, Duret T, Bernard-Stoecklin S, Perez-Bercoff D, Oblette A, Lina B, Rameix-Welti MA, Josset L, Enouf V, Bal A; RELAB study group. De Clercq A, et al. Among authors: enouf v. Euro Surveill. 2026 Jan;31(2):2500992. doi: 10.2807/1560-7917.ES.2026.31.2.2500992. Euro Surveill. 2026. PMID: 41540925 Free PMC article.
Recommendations for estimating and reporting vaccine effectiveness by time since vaccination: a COVID-19 case study.
Kissling E, Nunes B, Hooiveld M, Martínez-Baz I, Monge S, Robertson C, Knol M, Sève N, Mlinarić I, Domegan L, Machado A, Whitaker H, Lazar M, Meijer A, Enkirch T, Casado I, Pérez-Gimeno G, William N, Enouf V, Kurečić Filipović S, McKenna A, Rodrigues AP, de Lusignan S, Timnea OC, Latorre-Margalef N, Castilla J, Pozo F, Hamilton M, Masse S, Ilić M, Basile L, O'Donnell J, Guiomar R, Riess M, Popescu RM, Rose AMC, Andrews N, Bacci S, Pastore Celentano L, Valenciano M, Moren A, Beutels P, Hens N; I-MOVE-COVID-19 and ECDC primary care study teams. Kissling E, et al. Among authors: enouf v. Am J Epidemiol. 2026 Mar 17;195(4):1108-1119. doi: 10.1093/aje/kwaf254. Am J Epidemiol. 2026. PMID: 41246933 Free PMC article.
Influenza vaccine effectiveness and genetic diversity: insights from end-of-season community surveillance, France, 2024-2025.
Clercq A, Blanquart F, Vieillefond V, Visseaux B, Chakra CNA, Nunes MC, Jacques A, Haim-Boukobza S, Wehrle V, Deleglise G, Duret T, Bernard-Stoecklin S, Bercoff DP, Lina B, Rameix-Welti MA, Josset L, Enouf V, Bal A; RELAB study group. Clercq A, et al. Among authors: enouf v. Emerg Microbes Infect. 2025 Dec;14(1):2562045. doi: 10.1080/22221751.2025.2562045. Epub 2025 Oct 11. Emerg Microbes Infect. 2025. PMID: 40955037 Free PMC article.
Community and Hospital-Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS-CoV-2 During the 2023-2024 Season, Lyon, France.
Chauvel C, Casalegno JS, Visseaux B, Vieillefond V, Haim-Boukozba S, Enouf V, Chanard E, Fabre M, Rameix-Welti MA, Oblette A, Giannoli JM, Paireau J, Josset L, Lina B, Gaymard A, Cauchemez S, Morfin F, Nunes MC, Bal A. Chauvel C, et al. Among authors: enouf v. J Med Virol. 2025 Sep;97(9):e70549. doi: 10.1002/jmv.70549. J Med Virol. 2025. PMID: 40880188 Free PMC article.
Influenza vaccine effectiveness in Europe and the birth cohort effect against influenza A(H1N1)pdm09: VEBIS primary care multicentre study, 2023/24.
Kissling E, Maurel M, Pozo F, Pérez-Gimeno G, Buda S, Sève N, Domegan L, Hooiveld M, Oroszi B, Martínez-Baz I, Guiomar R, Latorre-Margalef N, Mlinarić I, Lazar M, Giménez Duran J, Dürrwald R, Enouf V, McKenna A, de Lange M, Túri G, Trobajo-Sanmartín C, Gomez V, Samuelsson Hagey T, Višekruna Vučina V, Cherciu MC, García Vazquez M, Erdwiens A, Masse S, Bennett C, Meijer A, Kristóf K, Castilla J, Rodrigues AP, Kurečić Filipović S, Ivanciuc AE, Bacci S, Kaczmarek M; European primary care VE group. Kissling E, et al. Among authors: enouf v. Euro Surveill. 2025 Jun;30(23):2500011. doi: 10.2807/1560-7917.ES.2025.30.23.2500011. Euro Surveill. 2025. PMID: 40511473 Free PMC article.
171 results